Registration
 
All news
Top Stories
Editors' Picks
Stocks
Crypto
Economics
Currencies
Commodities
Business & Wealth
Market Voices
Oleg Tkachenko
Oleg Tkachenko

Arvinas unveils preclinical findings for HPK1 and pan-KRAS PROTAC candidates

Arvinas unveils preclinical findings for HPK1 and pan-KRAS PROTAC candidates
Arvinas reveals new PROTAC data

Arvinas is presenting preclinical data for its PROTAC HPK1 degrader and pan-KRAS degrader during poster sessions at the AACR Annual Meeting this week.

The company aims to highlight scientific advancements in targeted protein degradation therapies for cancer treatment. Both degraders represent early-stage innovations in oncology, offering new approaches to disrupt critical signaling pathways. Attendees can learn more about the meeting and Arvinas’ research by visiting the official event website.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Editor's Picks for You

From Bitcoin to AI: How crypto companies are reinventing their businesses
  • By Olena Litvinenko
  • 18 hours ago
From Bitcoin to AI: How crypto companies are reinventing their businesses
Editors' Picks
Trezor security chief: It's easier to trick users than hack a crypto wallet
  • By Eugene Komchuk
  • 19 hours ago
Trezor security chief: It's easier to trick users than hack a crypto wallet
Editors' Picks
How Ozempic and weight-loss drugs are quietly deflating beer volumes
  • By Dmytro Kharkov
  • 20 hours ago
How Ozempic and weight-loss drugs are quietly deflating beer volumes
Editors' Picks
All Editors' Top Picks

Latest Arvinas News

First PROTAC protein degrader approval advances targeted protein degradation, Arvinas states
  • By Ksenia Gerey
  • 19.10.2026
First PROTAC protein degrader approval advances targeted protein degradation, Arvinas states
Companies
#Arvinas
Arvinas presents new oculomotor and biomarker data from Phase 1 trial in Parkinson Disease
  • By Oksana Koneva
  • 07.10.2026
Arvinas presents new oculomotor and biomarker data from Phase 1 trial in Parkinson Disease
Companies
#Arvinas
Arvinas unveils clinical data for experimental LRRK2 degrader
  • By Ksenia Gerey
  • 02.10.2026
Arvinas unveils clinical data for experimental LRRK2 degrader
Companies
#Arvinas
All Arvinas News
  • Olena Litvinenko
  • 18 hours ago
From Bitcoin to AI: How crypto companies are reinventing their businesses
  • Eugene Komchuk
  • 19 hours ago
Trezor security chief: It's easier to trick users than hack a crypto wallet
  • Dmytro Kharkov
  • 20 hours ago
How Ozempic and weight-loss drugs are quietly deflating beer volumes
  • Pavlo Kot
  • Yesterday
Q-Day for BTC: What happens if a quantum computer breaks Bitcoin?
  • Pavlo Kot
  • 24.10.2026
The cost of failure: Five of the most expensive digital outages
  • Oksana Koneva
  • 19 min ago
Kevin Susanto: Binance Pumpkin Camp offers 10 days of crypto education and $6,000 USDC reward
  • Eugene Komchuk
  • 1 hour ago
Mike Bird: Evergrande creditors received unusually clear warnings before investment losses
  • Alena Volkova
  • 1 hour ago
Voucher spending and affordable unit costs are similar over 50 years, Paul Williams notes
  • Mikhail Vnuchkov
  • 1 hour ago
Software may outperform semiconductors, Scott notes
  • Mykhailo Ihnatenko
  • 1 hour ago
Joao Wedson: ETF SATO often shows weakness before Bitcoin movement
Top News
  • Olga Shendetskaya
  • 13 hours ago
Brent holds above $110 as attacks in Saudi Arabia rattle oil markets
Brent holds above $110 as attacks in Saudi Arabia rattle oil markets
  • Igor Krasulya
  • 14 hours ago
EU prepares new tariffs on Chinese goods as trade tensions rise
EU prepares new tariffs on Chinese goods as trade tensions rise
  • Eugene Komchuk
  • 15 hours ago
Anthropic files for IPO, plans Nasdaq listing
Anthropic files for IPO, plans Nasdaq listing
  • Eugene Komchuk
  • 17 hours ago
Brazilian markets plunge after presidential election
Brazilian markets plunge after presidential election
  • Eugene Komchuk
  • 19 hours ago
Trezor security chief: It's easier to trick users than hack a crypto wallet
Trezor security chief: It's easier to trick users than hack a crypto wallet
Live News
  • Hanna Syniavska
  • Now
Revolut launches UK personal loans as it expands beyond everyday banking
  • Anton Kharitonov
  • Now
EUR/USD remains under pressure as eurozone growth weakens ahead of ECB decision
  • Hanna Syniavska
  • Now
Turkey tightens investor rules after fund crisis affects at least 500,000 people
  • Pavlo Kot
  • Now
Bank of Israel rejects Netanyahu's proposal to use crypto to bypass sanctions
  • Ezequiel Gomes
  • Now
New York attorney general seeks $1.37 billion from NovaTech crypto scheme founders
Who We Are
Business Solutions
For Users
TU News
Popular Sections
Disclosures
CONTACT US
Legal
We are in Social Media
© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186
  • Risk disclosure:

    Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

    That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.

  • Disclaimer:

    Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

    Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.

  • Disclosure of advertisers and revenues:

    All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

    Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.

onepercentfortheplanet.org https://gdpr.eu/ GDPR World Association of News Publishers